BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 12374697)

  • 1. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer.
    Reinmuth N; Liu W; Fan F; Jung YD; Ahmad SA; Stoeltzing O; Bucana CD; Radinsky R; Ellis LM
    Clin Cancer Res; 2002 Oct; 8(10):3259-69. PubMed ID: 12374697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer.
    Reinmuth N; Fan F; Liu W; Parikh AA; Stoeltzing O; Jung YD; Bucana CD; Radinsky R; Gallick GE; Ellis LM
    Lab Invest; 2002 Oct; 82(10):1377-89. PubMed ID: 12379772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45.
    Li H; Adachi Y; Yamamoto H; Min Y; Ohashi H; Ii M; Arimura Y; Endo T; Lee CT; Carbone DP; Imai K; Shinomura Y
    Cancer; 2011 Jul; 117(14):3135-47. PubMed ID: 21264842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.
    Stoeltzing O; Liu W; Reinmuth N; Fan F; Parikh AA; Bucana CD; Evans DB; Semenza GL; Ellis LM
    Am J Pathol; 2003 Sep; 163(3):1001-11. PubMed ID: 12937141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line.
    Kondo Y; Arii S; Mori A; Furutani M; Chiba T; Imamura M
    Clin Cancer Res; 2000 Feb; 6(2):622-30. PubMed ID: 10690548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
    Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM
    Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I.
    Akagi Y; Liu W; Zebrowski B; Xie K; Ellis LM
    Cancer Res; 1998 Sep; 58(17):4008-14. PubMed ID: 9731515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
    Li D; Williams JI; Pietras RJ
    Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
    Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G
    Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
    Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
    Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
    Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation.
    Yin YJ; Salah Z; Maoz M; Even Ram SC; Ochayon S; Neufeld G; Katzav S; Bar-Shavit R
    FASEB J; 2003 Feb; 17(2):163-74. PubMed ID: 12554695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
    Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
    Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.